<DOC>
	<DOCNO>NCT00917722</DOCNO>
	<brief_summary>In study , investigator follow patient stimulators implant , usual clinic follow-up appointment 3 , 6 , 9 12 month surgery . It typical appointment patient medication stimulators turn observe disease progress test stimulator effectiveness . Also part standard clinical practice , stimulator setting adjust optimal benefit motor symptom . Only patient already implant invite participate study , change stimulator setting make purpose study . Stimulator setting change base clinical evaluation motor symptom , study bearing stimulators set often set .</brief_summary>
	<brief_title>Deep Brain Stimulation Subthalamic Nucleus ( STN ) Cognitive Control</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Meet criterion `` definite '' Parkinson 's Disease ( PD ) STN stimulators side ( right left ) Surgery do Washington University within 2 year Significant visual deficit ( e.g . double vision , untreated eyelid apraxia , blepharospasm ) Must able see screen Secondary Parkinsonism ( druginduced know etiology ) Brain injury defect : history serious head injury , stroke , encephalitis , defect find brain image Early severe dementia ( within first year onset ) cholinesterase inhibitor Presurgical Mini Mental Status exam score &lt; 24 Significant current psychiatric diagnosis ( depression psychosis ) neuroleptic</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>STN DBS</keyword>
	<keyword>Deep Brain Stimulation</keyword>
</DOC>